143 related articles for article (PubMed ID: 10698241)
1. Selective screening for chlamydial infection: which criteria to use?
Miller WC; Hoffman IF; Owen-O'Dowd J; McPherson JT; Privette A; Schmitz JL; Woodlief G; Leone PA
Am J Prev Med; 2000 Feb; 18(2):115-22. PubMed ID: 10698241
[TBL] [Abstract][Full Text] [Related]
2. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy.
Marrazzo JM; Celum CL; Hillis SD; Fine D; DeLisle S; Handsfield HH
Sex Transm Dis; 1997 Mar; 24(3):131-41. PubMed ID: 9132979
[TBL] [Abstract][Full Text] [Related]
3. Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays.
Howell MR; Quinn TC; Brathwaite W; Gaydos CA
Sex Transm Dis; 1998 Feb; 25(2):108-17. PubMed ID: 9518379
[TBL] [Abstract][Full Text] [Related]
4. Predicting Neisseria gonorrhoeae and Chlamydia trachomatis infection using risk scores, physical examination, microscopy, and leukocyte esterase urine dipsticks among asymptomatic women attending a family planning clinic in Kenya.
Tyndall MW; Kidula N; Sande J; Ombette J; Temmerman M
Sex Transm Dis; 1999 Sep; 26(8):476-82. PubMed ID: 10494940
[TBL] [Abstract][Full Text] [Related]
5. Selective screening for Chlamydia trachomatis infection in nonurban family planning clinics in Wisconsin.
Addiss DG; Vaughn ML; Holzhueter MA; Bakken LL; Davis JP
Fam Plann Perspect; 1987; 19(6):252-6. PubMed ID: 3436412
[TBL] [Abstract][Full Text] [Related]
6. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies.
Howell MR; Quinn TC; Gaydos CA
Ann Intern Med; 1998 Feb; 128(4):277-84. PubMed ID: 9471930
[TBL] [Abstract][Full Text] [Related]
7. Chlamydia trachomatis infection in women attending urban midwestern family planning and community health clinics: risk factors, selective screening, and evaluation of non-culture techniques.
Addiss DG; Vaughn ML; Golubjatnikov R; Pfister J; Kurtycz DF; Davis JP
Sex Transm Dis; 1990; 17(3):138-46. PubMed ID: 2247804
[TBL] [Abstract][Full Text] [Related]
8. Chlamydia positivity versus prevalence. What's the difference?
Dicker LW; Mosure DJ; Levine WC
Sex Transm Dis; 1998 May; 25(5):251-3. PubMed ID: 9587176
[TBL] [Abstract][Full Text] [Related]
9. Chlamydia trachomatis infection among Hispanic women in the California-Mexico border area, 1993: establishing screening criteria in a primary care setting.
Gunn RA; Hillis SD; Shirey P; Waterman SH; Greenspan JR
Sex Transm Dis; 1995; 22(6):329-34. PubMed ID: 8578402
[TBL] [Abstract][Full Text] [Related]
10. A tale of two sexually transmitted diseases. Prevalences and predictors of chlamydia and gonorrhea in women attending Colorado family planning clinics.
Gershman KA; Barrow JC
Sex Transm Dis; 1996; 23(6):481-8. PubMed ID: 8946633
[TBL] [Abstract][Full Text] [Related]
11. Cost-benefit analysis of selective screening criteria for Chlamydia trachomatis infection in women attending Colorado family planning clinics.
Humphreys JT; Henneberry JF; Rickard RS; Beebe JL
Sex Transm Dis; 1992; 19(1):47-53. PubMed ID: 1561588
[TBL] [Abstract][Full Text] [Related]
12. Patterns of Chlamydia trachomatis testing and follow-up at a University Hospital Medical Center.
Bachmann LH; Richey CM; Waites K; Schwebke JR; Hook EW
Sex Transm Dis; 1999 Oct; 26(9):496-9. PubMed ID: 10534201
[TBL] [Abstract][Full Text] [Related]
13. Selective screening versus presumptive treatment criteria for identification of women with chlamydial infection in public clinics: New Jersey.
Finelli L; Nakashima AK; Hillis S; Crayne E; Spitalny KC
Am J Obstet Gynecol; 1996 May; 174(5):1527-33. PubMed ID: 9065124
[TBL] [Abstract][Full Text] [Related]
14. Developments in the screening for Chlamydia trachomatis: a review.
Kohl KS; Markowitz LE; Koumans EH
Obstet Gynecol Clin North Am; 2003 Dec; 30(4):637-58. PubMed ID: 14719842
[TBL] [Abstract][Full Text] [Related]
15. Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in family planning clinics in Wisconsin.
Addiss DG; Vaughn ML; Ludka D; Pfister J; Davis JP
Sex Transm Dis; 1993; 20(1):28-35. PubMed ID: 8430355
[TBL] [Abstract][Full Text] [Related]
16. Selective screening for chlamydial infection in women: a comparison of three sets of criteria.
Marrazzo JM; Fine D; Celum CL; DeLisle S; Handsfield HH
Fam Plann Perspect; 1997; 29(4):158-62. PubMed ID: 9258646
[TBL] [Abstract][Full Text] [Related]
17. Chlamydia trachomatis infection in women: a need for universal screening in high prevalence populations?
Weinstock HS; Bolan GA; Kohn R; Balladares C; Back A; Oliva G
Am J Epidemiol; 1992 Jan; 135(1):41-7. PubMed ID: 1736659
[TBL] [Abstract][Full Text] [Related]
18. Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics.
Handsfield HH; Jasman LL; Roberts PL; Hanson VW; Kothenbeutel RL; Stamm WE
JAMA; 1986 Apr; 255(13):1730-4. PubMed ID: 3081742
[TBL] [Abstract][Full Text] [Related]
19. Chlamydia trachomatis and human papillomavirus infection in Indian women with sexually transmitted diseases and cervical precancerous and cancerous lesions.
Gopalkrishna V; Aggarwal N; Malhotra VL; Koranne RV; Mohan VP; Mittal A; Das BC
Clin Microbiol Infect; 2000 Feb; 6(2):88-93. PubMed ID: 11168078
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for Chlamydia trachomatis infection in 6810 young women attending family planning clinics.
Ramstedt K; Forssman L; Giesecke J; Granath F
Int J STD AIDS; 1992; 3(2):117-22. PubMed ID: 1571382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
